Leask, A. (2009). Thrombin-induced CCN2 expression as a target for anti-fibrotic therapy in scleroderma. Springer Netherlands.
استشهاد بنمط شيكاغوLeask, Andrew. Thrombin-induced CCN2 Expression As a Target for Anti-fibrotic Therapy in Scleroderma. Springer Netherlands, 2009.
MLA استشهادLeask, Andrew. Thrombin-induced CCN2 Expression As a Target for Anti-fibrotic Therapy in Scleroderma. Springer Netherlands, 2009.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.